127 related articles for article (PubMed ID: 19669932)
1. Relationship between functional promoter polymorphism in the XBP1 gene (-116C/G) and atherosclerosis, ischemic stroke and hyperhomocysteinemia.
Yilmaz E; Akar R; Eker ST; Deda G; Adiguzel Y; Akar N
Mol Biol Rep; 2010 Jan; 37(1):269-72. PubMed ID: 19669932
[TBL] [Abstract][Full Text] [Related]
2. Relationship between functional promoter polymorphism in the XBP1 gene (-116C/G) and obesity.
Yilmaz E; Berberoglu M; Akar N
Clin Appl Thromb Hemost; 2010 Feb; 16(1):99-102. PubMed ID: 18840627
[TBL] [Abstract][Full Text] [Related]
3. The -116C/G polymorphism in XBP1 gene is associated with psychiatric illness in Asian population: A meta-analysis.
Cheng D; Zhang K; Zhen G; Xue Z
Am J Med Genet B Neuropsychiatr Genet; 2014 Dec; 165B(8):665-72. PubMed ID: 25231123
[TBL] [Abstract][Full Text] [Related]
4. Polymorphism - 116C/G of the human X box binding protein 1 gene is associated with risk of type 2 diabetes in a Chinese Han population.
Liu S; Ma G; Yao S; Chen Z; Wang C; Zhao B; Li K
Gene; 2016 Jan; 575(1):71-4. PubMed ID: 26299655
[TBL] [Abstract][Full Text] [Related]
5. Association of the XBP1-116C/G polymorphism with schizophrenia in the Japanese population.
Kakiuchi C; Ishiwata M; Umekage T; Tochigi M; Kohda K; Sasaki T; Kato T
Psychiatry Clin Neurosci; 2004 Aug; 58(4):438-40. PubMed ID: 15298659
[TBL] [Abstract][Full Text] [Related]
6. Association study of a functional promoter polymorphism in the XBP1 gene and schizophrenia.
Jönsson EG; Cichon S; Schumacher J; Abou Jamra R; Schulze TG; Deschner M; Forslund K; Hall H; Propping P; Czerski PM; Dmitrak-Weglarz M; Kapelski P; Driessen M; Maier W; Hauser J; Rietschel M; Nöthen MM
Am J Med Genet B Neuropsychiatr Genet; 2006 Jan; 141B(1):71-5. PubMed ID: 16342282
[TBL] [Abstract][Full Text] [Related]
7. Polymorphism -116C/G of human X-box-binding protein 1 promoter is associated with risk of Alzheimer's disease.
Liu SY; Wang W; Cai ZY; Yao LF; Chen ZW; Wang CY; Zhao B; Li KS
CNS Neurosci Ther; 2013 Apr; 19(4):229-34. PubMed ID: 23421912
[TBL] [Abstract][Full Text] [Related]
8. A possible association between the -116C/G single nucleotide polymorphism of the XBP1 gene and lithium prophylaxis in bipolar disorder.
Masui T; Hashimoto R; Kusumi I; Suzuki K; Tanaka T; Nakagawa S; Kunugi H; Koyama T
Int J Neuropsychopharmacol; 2006 Feb; 9(1):83-8. PubMed ID: 15927087
[TBL] [Abstract][Full Text] [Related]
9. XBP1 gene polymorphism (-116C/G) and personality.
Kato C; Kakiuchi C; Umekage T; Tochigi M; Kato N; Kato T; Sasaki T
Am J Med Genet B Neuropsychiatr Genet; 2005 Jul; 136B(1):103-5. PubMed ID: 15892135
[TBL] [Abstract][Full Text] [Related]
10. Association study of a functional promoter polymorphism of the X-box binding protein 1 gene in Japanese patients with schizophrenia.
Watanabe Y; Fukui N; Muratake T; Amagane H; Kaneko N; Nunokawa A; Someya T
Psychiatry Clin Neurosci; 2006 Oct; 60(5):633-5. PubMed ID: 16958950
[TBL] [Abstract][Full Text] [Related]
11. Impaired endoplasmic reticulum stress response in B-lymphoblasts from patients with bipolar-I disorder.
So J; Warsh JJ; Li PP
Biol Psychiatry; 2007 Jul; 62(2):141-7. PubMed ID: 17217928
[TBL] [Abstract][Full Text] [Related]
12. XBP1 promoter polymorphism modulates platinum-based chemotherapy gastrointestinal toxicity for advanced non-small cell lung cancer patients.
Peng J; Chen YY; Yang LX; Zhao XY; Gao ZQ; Yang J; Wu WT; Wang HJ; Wang JC; Qian J; Chen HY; Jin L; Bai CX; Han BH; Lu DR
Lung Cancer; 2013 Jun; 80(3):333-8. PubMed ID: 23510626
[TBL] [Abstract][Full Text] [Related]
13. Genetic variation of promoter sequence modulates XBP1 expression and genetic risk for vitiligo.
Ren Y; Yang S; Xu S; Gao M; Huang W; Gao T; Fang Q; Quan C; Zhang C; Sun L; Liang Y; Han J; Wang Z; Zhang F; Zhou Y; Liu J; Zhang X
PLoS Genet; 2009 Jun; 5(6):e1000523. PubMed ID: 19543371
[TBL] [Abstract][Full Text] [Related]
14. X-box binding protein 1 (XBP1) C--116G polymorphisms in bipolar disorders and age of onset.
Hou SJ; Yen FC; Cheng CY; Tsai SJ; Hong CJ
Neurosci Lett; 2004 Sep; 367(2):232-4. PubMed ID: 15331160
[TBL] [Abstract][Full Text] [Related]
15. Lithium response and -116C/G polymorphism of XBP1 in Japanese patients with bipolar disorder.
Kakiuchi C; Kato T
Int J Neuropsychopharmacol; 2005 Dec; 8(4):631-2. PubMed ID: 15836800
[No Abstract] [Full Text] [Related]
16. Preliminary evidence on the association between XBP1-116C/G polymorphism and response to prophylactic treatment with valproate in bipolar disorders.
Kim B; Kim CY; Lee MJ; Joo YH
Psychiatry Res; 2009 Aug; 168(3):209-12. PubMed ID: 19564049
[TBL] [Abstract][Full Text] [Related]
17. Impaired feedback regulation of XBP1 as a genetic risk factor for bipolar disorder.
Kakiuchi C; Iwamoto K; Ishiwata M; Bundo M; Kasahara T; Kusumi I; Tsujita T; Okazaki Y; Nanko S; Kunugi H; Sasaki T; Kato T
Nat Genet; 2003 Oct; 35(2):171-5. PubMed ID: 12949534
[TBL] [Abstract][Full Text] [Related]
18. Common variants in PERK, JNK, BIP and XBP1 genes are associated with the risk of prediabetes or diabetes-related phenotypes in a Chinese population.
Feng N; Ma X; Wei X; Zhang J; Dong A; Jin M; Zhang H; Guo X
Chin Med J (Engl); 2014; 127(13):2438-44. PubMed ID: 24985580
[TBL] [Abstract][Full Text] [Related]
19. The integrated endoplasmic reticulum stress response in Leishmania amazonensis macrophage infection: the role of X-box binding protein 1 transcription factor.
Dias-Teixeira KL; Calegari-Silva TC; dos Santos GR; Vitorino Dos Santos J; Lima C; Medina JM; Aktas BH; Lopes UG
FASEB J; 2016 Apr; 30(4):1557-65. PubMed ID: 26678450
[TBL] [Abstract][Full Text] [Related]
20. Partial XBP1 knockdown does not affect viability of oligodendrocyte precursor cells exposed to new models of hypoxia and ischemia in vitro.
Kraskiewicz H; FitzGerald U
J Neurosci Res; 2011 May; 89(5):661-73. PubMed ID: 21337367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
